Because of imbalanced numbers of cognitive normal (CN) controls in each APOE group in Table 1, we excluded CN from the scatterplots. Participants with mild cognitive impairment (MCI) (n = 396) or Alzheimer Disease (AD) dementia (n = 112) were divided into 3 groups based on APOE genotypes: 0 APOE ε4 alleles (APOE ε4 = 0), 1 APOE ε4 allele (APOE ε4 = 1), and 2 APOE ε4 alleles (APOE ε4 = 2). Relationships between baseline plasma C-reactive protein (CRP) and trajectory cognitive tests or CSF AD biomarkers at baseline, 12 months, and 24 months were examined. Associations between baseline CRP and Mini-Mental State Examination (MMSE) scores (A), Clinical Dementia Rating Sum of Boxes (CDR-SB) score (B), CFS total tau (t-Tau) (C), and CFS phosphorylated tau (p-Tau) (D) are shown by using scatterplots with a linear regression line with 95% confidence bands (shaded area), the Pearson coefficient of correlation, and its p value.